Equity Research

Similar documents
Earnings get stamina from pension stake disposal

Equity Research

Lafarge Africa Plc. (WAPCO.NL)

EQUITY STRATEGY DIARY. Oyekunle Omotayo-Benson; Usman Olubajo

Profitability remained weak

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

MEDIA PRIMA (HOLD, EPS )

Fee income offsets margin pressure

Nigerian Inflation: Base effect to bow out as food pressures dictate CPI tone

Earnings sustainability and asset quality remain under pressure

FORTE OIL PLC. FORTE OIL PLC: emergence of a new energy giant? Recommendation: HOLD FORTE OIL PLC FULL YEAR 2014:

Manappuram Finance (MGFL IN) Healthy operating performance

Financial summary. Year

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

MCB Bank Limited FULL YEAR AND FOURTH QUARTER th February 2009

2018 BUDGET. Budget of Consolidation

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

Results Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

Total Nigeria Plc. (Total: NL)

Repco Home Finance REPCO IN

Larsen & Toubro Ltd.

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Nigeria Equities Financial Services August 23,

KDDL (KDDL IN) In expansion mode

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Wipro. 3QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 328. Recommendation: Hold

Key estimate revision. Financial summary. Year

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12.

HOLD Rating as per Large Cap 12 month investment period

Chow Tai Fook (1929 HK)

ARM Research. Economic Update -- October Economic Report Monthly update. Economic Research

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank (HDFCB IN) Continue to perform strong

BUY. State Bank of India (SBI) Banking RETAIL EQUITY RESEARCH. Outlook getting better. CMP Rs278 TARGET Rs310 RETURN 12% 17 th November 2016

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

ONGC. Result Update Q2 FY15

Indostar Capital Finance

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

Dangote Cement Plc. Improved Product Pricing Boosts Earnings. Nigeria Equities Industrial Goods April 3, 2018

AutoZone, Inc. EQUITY RESEARCH QUARTERLY UPDATE OUTPERFORM. Quick Read: Sales a Bit Soft, But Results Solid. September 22, 2016

Korea Zinc (010130) Company Note. 1Q12 preview: Not over until it s over. BUY (Maintain)

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

Pharmaniaga MARKET PERFORM. 1Q15 Inline but Rich Valuations. Results Note. Price: RM6.91 Target Price: RM6.95. PP7004/02/2013(031762) Page 1 of 5

Key estimate revision. Financial summary. Year

Duksan Hi-Metal (077360)

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Key Developments in Domestic Economic and Policy Environment

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

FY17 FY18 FY19E FY20E

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

TAV Airports EARNINGS REVIEW 4Q17. Bottom-line below consensus BUY TRY22.90

Kingsoft (3888 HK) Buy (maintained) Target price: HK$ Strong earnings recovery ahead amid continued revenue momentum; maintain Buy

ARM Research. Economic Update July Economic Report Monthly Update. 9 August FMDQ ignites further FX liquidity flame.

HDFC Bank Banking BUY RETAIL EQUITY RESEARCH

CMP: Stock Data Sector. Stock Performance (%) Shareholding Pattern (%) Sensex and stock movement. 6 th March, 2017

HDFC Bank Banking. BUY Rating as per Large Ccap 12 month investment period RETAIL EQUITY RESEARCH

OANDO PLC. Oando PLC: to be or not to be? Investment Summary & Highlight. MorganCapital Research. July 3, 2013

Canara Bank. CMP: INR419 TP: INR525 Buy

Company Overview. Industry Overview. Financial Performance

The Company for Cooperative Insurance Insurance TAWUNIYA AB 8010.SE

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Capacity expansion to drive growth and profitability

KPR Mills Ltd 1QFY18 Result Update Target: Rs 944. Textile revenue impacted by slowdown due to GST, recovery from 2QFY18 onwards

Mphasis. 1QFY17 Result Update. Muted quarter, Direct business still weak. Sector: Technology CMP: ` 540. Recommendation: Sell

Tech Mahindra. 1QFY18 Result Update. Steps in the right direction, compelling valuation. Sector: Technology CMP: ` 385. Recommendation: Buy

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74

Guinness Nigeria Plc. Revenue growth remains a challenge. Nigeria Equities Breweries November 22, 2013

BUY SREI (SREI) Banks/Financial Institutions

Dismal 2Q15. Results Note. Price: RM8.49 Target Price: RM8.93. By Desmond Chong l PP7004/02/2013(031762) Page 1 of 6

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

HDFC Bank ACCUMULATE. Performance Highlights. CMP `2,348 Target Price `2,671. 4QFY2011 Result Update Banking. Key financials

Qatar National Bank (QNB)

PT Bukit Asam Tbk. Margin Expansion. BUY (TP: IDR 13,250) 23 October 2017

Below Expectations. Results Note. Price: RM6.95 Target Price: RM4.89. By Desmond Chong l PP7004/02/2013(031762) Page 1 of 5

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

MCB Bank Limited SECOND QUARTER th August 2008

Rough Start. Results Note. Price: RM5.40 Target Price: RM4.95. By Desmond Chong l

ASHAKACEM. Vetiva Research. Q3 10 Earnings Release. Margins under pressure? 4 November Fair Value Range N21.76 N24.05

S-Oil (010950) Healthier revenue structure already reflected in valuations

SEVEN-UP BOTTLING COMPANY PLC

Simmtech (222800) Focus on 2H earnings WHAT S THE STORY?

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

LG International (001120) Poor 3Q expected to be just a blip WHAT S THE STORY? SUMMARY OF 3Q RESULTS

Zenith Bank Plc. Earnings Below Expectation: Lower Provision for Loan Loss Saves the Day. Nigeria Equities Financial Services August 15, 2018

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

SEVEN-UP BOTTLING COMPANY PLC

MCB Bank Limited FIRST QUARTER 2009

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

State Bank of India (SBI) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

Fila Korea (081660) Widespread growth potential

FY17 FY18 FY19E FY20E

YG Entertainment (122870)

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Transcription:

Equity Research research@armsecurities.com.ng +234 1 270 1652 29 April 2016 Access Bank Plc. Earnings Report 3 months ended 31 st March, 2016 Benign funding costs and provisioning drive strong Q1 (STRONG BUY N5.55) Access Bank Plc. (Access) reported 5% rise in gross earnings to N80.3 billion, and in a departure from soft earnings growth thus far in Q1 16, the bank recorded stronger earnings growth with PBT and PAT climbing 37% and 42% YoY to N22.5 billion and N19.4 billion respectively. Faster loan growth fuels interest income strength Over Q1 16, Access reported 5% QoQ expansion in net loans (+26% YoY) largely reflecting increased participation in the various on-lending programs to state governments. Amid a largely stagnant pattern in asset yields, the higher loan volumes drove stronger interest income over the period (+6% QoQ, +19% YoY). Income Statement Data 2016 3M'm 2015 3M'm %chg Gross Earnings 80,272 76,792 5% PBT 22,583 16,517 37% Tax (3,164) (2,850) 11% PAT 19,419 13,668 42% Balance Sheet Data 2016-Mar 'm 2015 -Dec'm %chg Cash 506,587 478,409 6% Loans 1,437,882 1,365,831 5% Deposits 1,803,387 1,683,244 7% Fixed Asset 75,488 73,330 3% Net Assets 382,481 367,801 4% Stock Data Price N4.06 52 week range N3.48 N6.38 Market Cap. (N'm) 117,447 1-month Avg. Vol 6,488,135 Curr. PE 1.5x Bloomberg Ticker ACCESS:NL Access Bank Plc- Share Price Trend The impact of the balance sheet expansion helped mute impact of lower NIR (-31% YoY, -23% QoQ) over Q1 16. Weakness on this front reflects offsetting impact of a N3.3 billion loss in HFT (of which N2.7 billion is related to derivatives) and a drop in other income. Access management notes that on maturity of a derivative contract, valuation gains cycle through trading income with any losses on the spot exchange rate on contract closure is captured under HFT. Analyst(s) Wale Okunrinboye adewale.okunrinboye@arm.com.ng

Dovish monetary policy and mild provisioning buoy earnings Despite a 7% QoQ rise in deposits, driven by higher term deposits (+2pps to 44%), impact of the lower rate environment over much of Q1 was evident on Access numbers with interest expense declining 9% QoQ (and YoY). This resulted in a 60bps QoQ (-140bps YoY) drop in WACF to a twenty quarter low of 3.7%. Furthermore, OPEX growth was largely contained (-14% QoQ, +2% YoY) which drove improvement in cost-to-income ratio (YoY: -4.3pps, QoQ: -12pps) of 58%. At N2.4 billion, (-10% QoQ, -38% YoY) provisioning was mild with cost of risk sliding 70bps YoY (-10bps QoQ) to 0.7% as NPLs were largely flat from December at 1.7%. Access low provisioning reflects lower upstream O&G exposure (5% of total loans) and a lower price deck on these exposures. Supported by high coverage ratios of 215% and robust CAR levels (19.6%), Access has the buffers in place to manage the current weak economic cycle. Over the subsequent quarters of 2016, Access high share of term deposits raises prospects for an erosion of Q1 16 funding cost gains as monetary policy stance turns hawkish. Nonetheless, Access management guides that the bank still has 65% of its HFT forward positions ($1.7 billion) yet to mature at the end of Q1 16, which stokes prospects for sustained NIR gains over the rest of 2016. Access current P/E and P/B of 1.5x and 0.3x is in line with peer average. We are positive on Access, with 37% upside implied in our FVE (N5.55) relative to last trading price, keeping our STRONG BUY rating on the stock intact.

Summary of Results and Forecasts - Naira (N million) QUARTERLY Income Statement * Q1 2016A Q1 2016E Q2 2016E Q3 2016E Q4 2016E Gross earnings 80,272 82,001 82,151 86,473 94,970 Interest Income 55,437 58,341 59,327 62,787 67,532 Interest Expense (20,814) (23,808) (26,779) (28,821) (34,121) Net interest income 34,623 34,533 32,548 33,966 33,411 Non-Interest Revenue 24,737 23,661 22,824 23,686 27,438 OPEX (34,378) (37,027) (33,355) (35,811) (41,214) Provisions (2,398) (2,866) (11,283) (2,311) (4,954) PBT 22,583 18,301 10,734 19,529 14,681 Tax (3,164) (2,379) (1,395) (2,539) (1,909) PAT 19,419 15,922 9,339 16,990 12,773 ANNUAL Income Statement (N 000)* FY 2014A FY 2015A FY 2016F FY 2017F FY 2018F Gross earnings 245,218 337,404 345,596 346,888 369,778 Interest Income 176,918 207,803 247,987 261,338 279,951 Interest Expense (76,901) (102,421) (113,529) (114,710) (118,671) Net interest income 100,017 105,382 134,458 146,628 161,280 Non-Interest Revenue 68,263 129,450 97,608 85,550 89,827 OPEX (104,605) (145,569) (147,407) (159,250) (172,402) Provisions (11,652) (14,225) (21,415) (15,325) (16,770) PBT 52,022 75,038 63,245 57,603 61,934 Tax (8,959) (9,169) (8,222) (7,488) (8,051) PAT 43,063 65,869 55,023 50,115 53,883 Balance Sheet (N 000)* Assets Net Loans 786,170 1,110,464 1,365,831 1,427,642 1,532,512 Fixed Assets 67,243 69,660 73,330 75,530 77,796 LT investment 417,221 357,284 389,939 497,905 522,800 Other Assets 54,970 104,616 161,099 173,830 188,972 Total Assets 1,835,466 2,104,361 2,591,330 2,715,472 2,853,671 Liabilities Deposits 1,454,419 1,683,244 1,767,407 1,855,777 1,948,566 Borrowings 221,567 386,889 410,102 434,708 460,791 Total liabilities 1,826,950 2,223,529 2,309,030 2,411,798 2,532,711 Shareholders' fund 277,411 367,801 406,442 441,873 479,968 Key Ratios FY 2014A FY 2015F FY 2016F FY 2017F FY 2018F EPS 1.88 2.59 1.90 1.73 1.86 DPS 0.60 0.34 0.57 0.52 0.56 BVPS 12.12 14.48 14.05 15.27 16.59 ROE 16.5% 18.3% 14.2% 11.8% 11.7% ROA 2.2% 2.6% 2.1% 1.8% 1.8% Financial Leverage 7.59 7.05 6.68 6.46 6.28 Asset yields 12.9% 11.5% 12.9% 12.9% 12.9% WACF 4.6% 4.8% 5.2% 5.0% 5.0% Net interest margins 7.3% 5.9% 7.0% 7.2% 7.4% Loan to Deposit 76% 81% 81% 83% 86% Cost to income 62% 62% 64% 69% 69% Liquidity ratio 28% 33% 29% 27% 26% CAR 18.2% 19.5% 21.3% 22.2% 23.0% Source: ARM Research *unless otherwise stated

ARM ratings and recommendations ARM now employs a two-tier rating system which is based on systemic importance of the security under review and the deviation of our target price for the stock from current market price. We characterize systemic importance as a function of a stock s ranking among the group of top 20 stocks by NSE market capitalization over a trailing 6 month period (minimum) to the review date. We adopt a 5 point rating system for this category of stocks and a 3 point rating system for stocks outside this group. The choice of top 20 stocks arises from the consideration that this group of stocks constitutes >75% of overall market capitalization and stocks outside this group are generally less liquid and individually account for <<1% of market capitalization. For stocks in both categories, the basis for ratings subject to target price deviation is outlined below: TOP 20 NON-TOP 20 Rating Deviation Rating Deviation STRONG BUY >20% BUY >20% OVERWEIGHT 10% 20 % NEUTRAL 5% 20 % NEUTRAL 0% 10 % SELL <5% UNDERWEIGHT -5% 0% SELL <-5% RECOMMENDATION KEY Rating BUY OVERWEIGHT NEUTRAL UNDERWEIGHT SELL Recommendation Accumulate security to a substantial extent constrained only by portfolio diversification considerations Accumulate security to an extent moderated by cognizance of its benchmark weight Maintain status quo for security with respect to current holding i.e. keep if already holding and don t buy otherwise subject t reasonable portfolio constraints Minimise exposure to security taking cognizance of its index weighting Sell-off security completely from portfolio

Copyright 2016 Asset & Resource Management Company Limited ( ARM ). All rights reserved. Unauthorised use, reproduction, distribution or disclosure of this document is strictly prohibited. This material has been issued by Asset & Resource Management Company Limited ( ARM ), a Company regulated by the Nigerian Securities and Exchange Commission. The analyst(s) primarily responsible for preparing this research report, in whole or in part, certifies that with respect to each security or issuer covered; all of the views expressed accurately reflect his/her personal views about the subject securities and issuers and no part of his/her compensation was, is, or will be, directly or indirectly, related to the inclusion of specific recommendations or views in the report. This research report is based on information from sources that ARM and its analysts believe to be reliable. Neither ARM nor any of its research analysts, nor any member of the ARM Group, gives any representation or warranty, express or implied, or undertaking of any kind or assumes responsibility or liability of any kind with respect to the accuracy or completeness of the information set out in this report or any third party s use (or the results of such use) of such information. This report is provided solely for informational purposes and is not to be construed as providing advice, recommendations, or endorsements of any kind whatsoever. The investments and strategies discussed here may not be suitable for all investors; counsel of investment advisor should be obtained with regard to such investments and or strategies. This research report is not a replacement for advice from an accountant, lawyer, personal finance advisor or other category of investment advisor. The investments discussed in this report may oscillate in price or value. Opinions and information provided are made as of the date of the report issue and are subject to change without notice. This research report is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Reference herein to any specific security or financial instrument does not necessarily constitute or imply its endorsement or recommendation by ARM, its directors, officers, employees or designated agents. Members of ARM may act as broker, advisor or lender, or make a market in any investments or issuers referenced in this report. Further information on any of the securities discussed herein may be obtained upon request to ARM. By accepting this document, you agree to be bound by the foregoing limitations.